Conclusion

While high-end companies like Ottobock and Ossur along with other listed global leading manufacturers are lauded for their innovative technology, most of their products have steep prices which limit access in LMIC. A recent shift has seen emerging companies in countries like China, India and Türkiye producing quality components for basic modular prostheses at more affordable prices. However, the ambiguous definition of ‘quality’ and the absence of widespread structural testing as well as field/clinical trials raise concerns about substandard, less durable products entering the market. Addressing these quality-control issues is crucial for providing durable, effective prostheses that are both innovative and accessible to those in LMICs, ensuring a balance between innovation, affordability, accessibility and sustainability.

114